National Health Act 1953 Determination under subsection 85B(1) (No. PB 15 of 2007) (Cth)

Case
No judgment structure available for this case.

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DETERMINATION UNDER SUBSECTION 85B(1)

No. PB 15 of 2007

I, STEPHEN DELLAR, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, pursuant to subsection 85B(1) of the National Health Act 1953 (referred to in this Determination as “the Act”), hereby make the following Determination:

1.          This Determination commences on 1 March 2007.

2. Determination No. PB 48 of 2006 under subsection 85B(1) of the National Health Act 1953 made on 


7 November 2006 with effect from 1 December 2006, as amended on 1 December 2006 with effect from 1 January 2007 (No. PB 5 of 2007), and on 5 January 2007 with effect from 1 February 2007


(No. PB 8 of 2007), is repealed.

3.          In this Determination “authority prescription” means a prescription which directs the supply of a pharmaceutical benefit and is a prescription authorised in accordance with paragraph 12 of the determinations made under sections 85, 85A and 88 of the Act.

4. Section 85B of the Act applies in relation to each of the brands of the pharmaceutical benefits specified in Part A of the Schedule to this Determination (referred to in this Determination as “the Schedule”).

5. For the purposes of paragraph 85B(1)(c) of the Act, the quantity or number of units that is relevant for the purpose of determining an amount referred to in paragraph 85B (1) (d) or 85B(1)(e) of the Act in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the quantity or number of units specified in Part B of the Schedule in relation to the brand of the pharmaceutical benefit.

6. For the purposes of paragraph 85B(1)(d) of the Act, the amount that is, for the purposes of Part VII of the Act, to be taken to be the manufacturer’s price for sales to approved pharmacists in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the amount specified in Part C of the Schedule in relation to the brand of the pharmaceutical benefit.

7. For the purposes of paragraph 85B(1)(e) of the Act, the amount that is, for the purposes of Part VII of the Act, to be taken to be the price claimed by the manufacturer as the manufacturer’s price for sales to approved pharmacists in relation to each brand of a pharmaceutical benefit specified in Part A of the Schedule is the amount specified in Part D of the Schedule in relation to the brand of the pharmaceutical benefit.

8.          The name of the manufacturer or the names of manufacturers denoted in accordance with the following table by letters appearing in the column headed “Brand” in Part A of the Schedule in relation to a pharmaceutical benefit specified in that Part of the Schedule is or are the brand or brands of the pharmaceutical benefit referred to in paragraphs 4, 5, 6 and 7:

Letters Manufacturer's Name Letters Manufacturer's Name
AB Abbott Australasia Pty Ltd AG Allergan Australia Pty Ltd
AL Alphapharm Medical A Division of Alphapharm Pty Limited AP AstraZeneca Pty Ltd
AQ Alcon Laboratories (Australia) Pty Ltd AS Aspen Pharmacare Australia Pty Ltd
AV Aventis Pharma Pty Limited BN Bayer Australia Limited
BP British Pharmaceuticals BQ Bristol-Myers Squibb Pharmaceuticals A Division of Bristol-Myers Squibb Australia Pty Ltd
BX Baxter Healthcare Pty Limited BY Boehringer Ingelheim Pty Limited
CS CSL Limited DT DermaTech Laboratories Pty Ltd
FR Charles E. Frosst Division of Merck Sharp & Dohme (Australia) Pty Ltd GC GlaxoSmithKline Consumer Healthcare
GK GlaxoSmithKline Australia Pty Ltd JC Janssen-Cilag Pty Ltd
LU Lundbeck Australia Pty Ltd LY Eli Lilly Australia Pty Limited
MK Merck Sharp & Dohme (Australia) Pty Ltd ML Marion Division of Aventis Pharma Pty Limited
MM 3M Pharmaceuticals Australia Pty Ltd MQ Merck Pharmaceuticals
MX Mayne Pharma Pty Ltd NM Novartis Medicines A Division of Novartis Pharmaceuticals Australia Pty Ltd
NV Novartis Pharmaceuticals Australia Pty Ltd OR Organon (Australia) Pty Limited
PC Pfizer Consumer Healthcare Pty Ltd PF Pfizer Pty Limited
PH Pharmacia Australia Pty Limited RO Roche Products Pty Ltd
SC Schering Pty Ltd Australian Subsidiary of Schering AG, Berlin SE Servier Laboratories (Aust.) Pty Ltd
SG Serono Australia Pty Ltd SI Sigma Pharmaceuticals Pty Ltd
SM Solvay Pharmaceuticals Division of Solvay Biosciences Pty Ltd SU Sauter Laboratories (Aust.) Pty Ltd
SW Sanofi-Synthelabo Australia Pty Limited SZ Sandoz Pty Ltd
UC UCB Pharma A Division of UCB Australia Pty Ltd VT Valeant Pharmaceuticals Australasia Pty Ltd
WY Wyeth Pharmaceuticals Division of Wyeth Australia Pty Limited
Aciclovir Tablet 200 mg GK 25 38.25 40.88
GK 90 139.97 143.86
Tablet 800 mg GK 35 169.57 171.47
GK 120 562.55 569.46
Alendronate Sodium Tablet equivalent to 70 mg alendronic acid MK 4 42.85 43.60
Allopurinol Tablet 100 mg SI 200 7.85 10.06
Tablet 300 mg SI 60 4.64 6.72
Alprazolam Tablet 250 micrograms PH 50 3.62 4.57
Tablet 500 micrograms PH 50 5.86 6.88
Tablet 1 mg PH 50 10.21 11.41
Tablet 2 mg PH 50 15.81 17.26
Aluminium Hydroxide - Dried with Magnesium Hydroxide Tablet 200 mg-200 mg PC 100 3.49 3.67
Oral suspension 200 mg-200 mg per 5 mL, 500 mL PC 1 3.49 3.63
Amiodarone Hydrochloride Tablet 100 mg SW 30 10.00 10.88
Tablet 200 mg SW 30 17.76 18.64
Amlodipine Besylate Tablet equivalent to 5 mg amlodipine (unless supplied on an authority prescription) PF 30 13.86 17.92
Tablet equivalent to 10 mg amlodipine (unless supplied on an authority prescription) PF 30 24.39 30.28
Amoxycillin Trihydrate Tablet equivalent to 1 g amoxycillin GK 14 5.06 6.42
SZ 14 5.06 6.42
Capsule equivalent to 250 mg amoxycillin GK 20 2.47 3.38
Capsule equivalent to 500 mg amoxycillin GK 20 4.91 5.82
Amoxycillin Trihydrate with Potassium Clavulanate Tablet equivalent to 500 mg amoxycillin-125 mg clavulanic acid GK 10 6.65 7.55
Tablet equivalent to 875 mg amoxycillin-125 mg clavulanic acid GK 10 9.48 10.66
Amoxycillin Trihydrate with Potassium Clavulanate and Water - Purified BP Powder for oral suspension equivalent to 125 mg amoxycillin-31.25 mg clavulanic acid per 5 mL, 75 mL GK 1 4.09 4.96
Powder for oral suspension equivalent to 400 mg amoxycillin-57 mg clavulanic acid per 5 mL, 60 mL GK 1 5.84 6.73
Amoxycillin Trihydrate with Water - Purified BP Powder for paediatric oral drops equivalent to 100 mg amoxycillin per mL, 20 mL (unless supplied on an authority prescription) GK 1 3.68 4.21
Powder for oral suspension equivalent to 125 mg amoxycillin per 5 mL, 100 mL GK 1 2.20 3.31
Powder for oral suspension equivalent to 250 mg amoxycillin per 5 mL, 100 mL GK 1 3.17 4.09
Aspirin Tablet 100 mg MX 112 1.41 2.61
Atenolol Tablet 50 mg AP 30 4.46 7.69
Azathioprine Tablet 25 mg GK 100 35.66 37.04
Tablet 50 mg GK 100 60.71 62.02
Baclofen Tablet 10 mg NV 100 29.74 32.37
Tablet 25 mg NV 100 65.05 67.69
Betamethasone Valerate Cream equivalent to 200 micrograms betamethasone per g, 100 g SI 1 3.76 6.49
Cream equivalent to 500 micrograms betamethasone per g, 15 g SI 1 1.89 3.58
Ointment equivalent to 500 micrograms betamethasone per g, 15 g SI 1 1.89 3.58
Betaxolol Hydrochloride Eye drops, solution, equivalent to 5 mg betaxolol per mL, 5 mL AQ 1 7.19 8.96
Bisacodyl Suppositories 10 mg, 10 BY 1 4.57 4.91
Bleomycin Sulfate with any determined brand of Sodium Chloride Injection Powder for injection 15,000 I.U. (with required solvent) MX 1 47.66 90.54
SI 10 476.63 905.38
BQ 10 476.63 979.29
Brimonidine Tartrate Eye drops 2 mg per mL, 5 mL AG 1 12.93 14.47
Brinzolamide Eye drops 10 mg per mL, 5 mL AQ 1 12.93 13.82
Bromocriptine Mesylate Tablet equivalent to 2.5 mg bromocriptine NV 30 12.67 15.25
NV 60 25.32 27.97
Capsule equivalent to 5 mg bromocriptine NV 60 49.79 52.44
Capsule equivalent to 10 mg bromocriptine NV 100 178.33 181.24
Bupropion Hydrochloride Tablet 150 mg (sustained release) GK 30 65.71 66.50
GK 90 150.38 151.17
Captopril Tablet 12.5 mg BQ 90 11.89 14.13
Tablet 25 mg BQ 90 17.21 19.45
Tablet 50 mg BQ 90 33.95 36.19
Carbamazepine Tablet 100 mg NV 200 14.75 17.48
Tablet 200 mg NV 200 27.57 30.57
Carbomer 980 Ocular lubricating gel 2 mg per g, 10 g NV 1 3.63 4.52
Cefaclor Monohydrate Tablet (sustained release) equivalent to 375 mg cefaclor AS 10 7.51 10.15
Cefaclor Monohydrate with Water - Purified BP Powder for oral suspension equivalent to 125 mg cefaclor per 5 mL, 100 mL AS 1 5.28 7.59
Powder for oral suspension equivalent to 250 mg cefaclor per  5 mL, 75 mL AS 1 5.65 8.04
Cefotaxime Sodium Powder for injection equivalent to 1 g cefotaxime SZ 1 1.88 4.28
Powder for injection equivalent to 2 g cefotaxime SZ 1 3.48 7.90
Cephalexin Capsule 250 mg (anhydrous) AS 20 2.81 4.98
Capsule 500 mg (anhydrous) AS 20 5.04 7.62
Cephalexin with Water - Purified BP Granules for oral suspension 125 mg per 5 mL, 100 mL AS 1 3.35 5.60
Granules for oral suspension 250 mg per 5 mL, 100 mL AS 1 4.97 7.54
Cephalothin Sodium Powder for injection equivalent to 1 g cephalothin AS 10 34.15 34.41
Cephazolin Sodium Powder for injection equivalent to 1 g cephazolin AS 10 55.76 57.96
Cimetidine Tablet 200 mg GK 120 17.35 19.62
Tablet 400 mg GK 60 17.35 19.62
Ciprofloxacin Hydrochloride Tablet equivalent to 250 mg ciprofloxacin BN 14 23.08 24.76
Tablet equivalent to 500 mg ciprofloxacin BN 14 45.10 46.78
Tablet equivalent to 750 mg ciprofloxacin BN 14 67.97 69.64
Eye drops equivalent to 3 mg ciprofloxacin per mL, 5 mL AQ 1 10.89 11.99
Citalopram Hydrobromide Tablet equivalent to 20 mg citalopram LU 28 19.16 21.97
Clarithromycin Tablet 250 mg AB 14 7.25 9.53
Clindamycin Hydrochloride Capsule equivalent to 150 mg clindamycin PH 25 12.33 13.61
Clomiphene Citrate Tablet 50 mg SG 10 30.93 31.09
AV 10 30.93 34.21
Clomipramine Hydrochloride Tablet 25 mg NV 50 12.07 15.04
Clonazepam Tablet 500 micrograms RO 100 7.99 10.07
Tablet 2 mg RO 100 15.02 17.38
Codeine Phosphate with Paracetamol Tablet 30 mg-500 mg SW 20 1.92 3.59
Colchicine Tablet 500 micrograms AS 100 4.00 4.81
Cyclosporin Capsule 25 mg NV 30 44.76 45.82
Capsule 50 mg NV 30 93.12 94.27
Capsule 100 mg NV 30 189.73 190.89
Cyproterone Acetate Tablet 50 mg SC 20 55.76 59.93
SC 50 122.20 124.20
Tablet 100 mg SC 50 197.98 199.99
Dexamethasone Sodium Metasulfobenzoate with Framycetin Sulfate and Gramicidin Ear drops 500 micrograms (dexamethasone)-5 mg-50 micrograms per mL, 8 mL AV 1 2.08 3.64
Diazepam Tablet 2 mg SU 50 1.80 2.59
RO 50 1.80 2.95
Tablet 5 mg SU 50 2.00 2.83
RO 50 2.00 3.16
Diclofenac Sodium Tablet 25 mg (enteric coated) NV 50 3.85 5.30
Tablet 50 mg (enteric coated) NV 50 5.37 8.18
Digoxin Tablet 62.5 micrograms SI 200 3.31 4.89
Tablet 250 micrograms SI 100 3.56 5.15
Diltiazem Hydrochloride Tablet 60 mg AV 90 12.98 15.30
Capsule 180 mg (controlled delivery) AV 30 14.40 16.72
Capsule 240 mg (controlled delivery) AV 30 19.44 21.76
Capsule 360 mg (controlled delivery) AV 30 25.49 28.31
Diphenoxylate Hydrochloride with Atropine Sulfate Tablet 2.5 mg-25 micrograms PH 20 1.71 3.33
Dothiepin Hydrochloride Capsule 25 mg AB 50 2.59 4.41
Tablet 75 mg AB 30 2.57 3.51
Doxepin Hydrochloride Capsule equivalent to 10 mg doxepin PF 50 2.22 3.84
Capsule equivalent to 25 mg doxepin PF 50 2.59 3.96
Doxycycline Hydrochloride Tablet equivalent to 50 mg doxycycline PF 25 4.23 5.68
Capsule equivalent to 50 mg doxycycline (containing enteric coated pellets) MX 25 4.23 5.74
Tablet equivalent to 100 mg doxycycline PF 7 2.37 3.76
Capsule equivalent to 100 mg doxycycline (containing enteric coated pellets) MX 7 2.37 3.70
MX 21 7.07 9.49
Enalapril Maleate Tablet 5 mg MK 30 7.78 10.64
Tablet 10 mg FR 30 12.78 15.64
MK 30 12.78 15.64
Tablet 20 mg FR 30 16.28 19.14
MK 30 16.28 19.14
Erythromycin Capsule 250 mg (containing enteric coated pellets) MX 25 3.49 5.05
Erythromycin Ethyl Succinate Tablet equivalent to 400 mg erythromycin AB 25 3.20 5.75
Erythromycin Ethyl Succinate with Water - Purified BP Powder for oral liquid equivalent to 200 mg erythromycin per 5 mL, 100 mL AB 1 2.88 4.81
Powder for oral liquid equivalent to 400 mg erythromycin per 5 mL, 100 mL AB 1 4.31 5.86
Escitalopram Oxalate Tablet equivalent to 10 mg escitalopram LU 28 20.40 23.31
Tablet equivalent to 20 mg escitalopram LU 28 32.75 37.61
Oral solution equivalent to 10 mg escitalopram per mL, 28 mL (unless supplied on an authority prescription) LU 1 27.54 31.47
Famotidine Tablet 20 mg MK 60 12.75 17.67
Tablet 40 mg MK 30 12.75 17.67
Felodipine Tablet 2.5 mg (extended release) AP 30 9.35 12.09
Tablet 5 mg (extended release) AP 30 12.87 15.92
Tablet 10 mg (extended release) AP 30 23.04 27.28
Flecainide Acetate Tablet 100 mg MM 60 36.62 39.14
Flucloxacillin Magnesium with Water - Purified BP Powder for oral suspension equivalent to 250 mg flucloxacillin per 5 mL, 100 mL GK 1 8.53 8.61
Flucloxacillin Sodium Capsule equivalent to 250 mg flucloxacillin GK 24 5.83 6.24
Capsule equivalent to 500 mg flucloxacillin GK 24 12.20 12.72
Fluoxetine Hydrochloride Tablet, dispersible, equivalent to 20 mg fluoxetine LY 28 16.68 23.01
Capsule equivalent to 20 mg fluoxetine LY 28 16.68 23.01
Fluvastatin Sodium Capsule equivalent to 20 mg fluvastatin NM 28 18.50 19.41
Capsule equivalent to 40 mg fluvastatin NM 28 22.68 23.58
Fluvoxamine Maleate Tablet 50 mg SM 30 16.17 19.60
Tablet 100 mg SM 30 24.49 27.92
Frusemide Tablet 20 mg AV 50 1.51 2.00
Tablet 40 mg AV 100 2.74 3.72
Gemfibrozil Tablet 600 mg PF 60 30.83 33.90
Glibenclamide Tablet 5 mg AV 100 4.68 5.76
Gliclazide Tablet 80 mg SE 100 8.23 10.59
Glimepiride Tablet 1 mg AV 30 3.10 5.29
Tablet 2 mg AV 30 5.94 8.13
Tablet 3 mg AV 30 7.62 9.83
Tablet 4 mg AV 30 9.32 11.52
Glipizide Tablet 5 mg PH 100 4.77 8.38
Glyceryl Trinitrate Tablets 600 micrograms, 100 SI 1 3.21 4.67
Hydrochlorothiazide with Amiloride Hydrochloride Tablet 50 mg-5 mg MK 50 2.82 4.32
Hydrocortisone Acetate Cream 10 mg per g, 30 g SI 1 1.61 3.29
Cream 10 mg per g, 50 g DT 1 2.02 2.09
SI 1 2.02 3.71
Ointment 10 mg per g, 30 g SI 1 1.61 3.29
Ointment 10 mg per g, 50 g SI 1 2.02 3.71
Hypromellose Eye drops 3 mg per mL, 15 mL NV 1 3.63 5.28
Hypromellose 4500 with Dextran 70 Eye drops 3 mg-1 mg per mL, 15 mL AQ 1 3.63 5.11
Hypromellose with Carbomer 980 Ocular lubricating gel 3 mg-2 mg per g, 10 g NV 1 3.63 5.28
Imipramine Hydrochloride Tablet 10 mg NV 50 1.76 3.31
Tablet 25 mg NV 50 1.76 3.31
Indapamide Hemihydrate Tablet 2.5 mg SE 90 12.83 15.79
Indomethacin Capsule 25 mg MK 50 2.45 3.81
Ipratropium Bromide Nebuliser solution 250 micrograms (anhydrous) in 1 mL single dose units, 30 BY 1 17.89 18.31
Nebuliser solution 500 micrograms (anhydrous) in 1 mL single dose units, 30 BY 1 21.15 21.56
Iron Polymaltose Complex Injection 100 mg (iron) in 2 mL ampoule BX 5 41.90 42.98
Isosorbide Dinitrate Tablet 10 mg SI 100 3.29 4.91
Isosorbide Mononitrate Tablet 60 mg (sustained release) AP 30 7.49 10.07
Tablet 120 mg (sustained release) AP 30 17.76 20.49
Isotretinoin Capsule 20 mg RO 60 127.43 129.63
Ketoprofen Capsule 200 mg (sustained release) AV 28 9.32 11.09
Labetalol Hydrochloride Tablet 100 mg SI 100 7.85 10.34
Tablet 200 mg SI 100 13.64 16.26
Lactulose Solution BP 3.34 g per 5 mL, 500 mL SM 1 9.05 10.99
Lamotrigine Tablet 5 mg GK 56 11.97 12.85
Tablet 25 mg GK 56 26.64 27.53
Tablet 50 mg GK 56 44.43 45.31
Tablet 100 mg GK 56 74.02 74.90
Tablet 200 mg GK 56 124.35 125.23
Lansoprazole Sachet containing granules for oral suspension, 30 mg per sachet (unless supplied on an authority prescription) WY 28 28.41 31.71
Leflunomide Tablet 10 mg AV 30 82.60 83.66
Tablet 20 mg AV 30 125.76 126.83
Lercanidipine Hydrochloride Tablet 10 mg (unless supplied on an authority prescription) SM 30 17.28 18.25
Tablet 20 mg (unless supplied on an authority prescription) SM 30 28.34 31.70
Levetiracetam Tablet 250 mg (unless supplied on an authority prescription) UC 60 45.45 51.94
Tablet 500 mg (unless supplied on an authority prescription) UC 60 75.80 86.63
Tablet 1 g (unless supplied on an authority prescription) UC 60 126.28 144.32
Levodopa with Carbidopa Tablet 100 mg-25 mg (anhydrous) MK 100 30.05 34.80
Tablet 250 mg-25 mg (anhydrous) MK 100 37.05 39.87
Levonorgestrel with Ethinyloestradiol Tablets 150 micrograms-30 micrograms, 21 SC 1 2.37 4.91
Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets WY 4 9.48 19.03
SC 1 2.37 4.91
Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets WY 4 9.48 19.03
SC 1 2.37 4.91
Lisinopril Tablet 5 mg MK 30 8.93 10.70
AP 30 8.93 11.34
Tablet 10 mg MK 30 13.41 15.18
AP 30 13.41 15.82
Tablet 20 mg MK 30 16.89 18.66
AP 30 16.89 19.30
Loperamide Hydrochloride Capsule 2 mg JC 12 1.71 2.53
Medroxyprogesterone Acetate Tablet 5 mg PH 56 7.80 9.35
Tablet 10 mg PH 30 8.37 9.92
PH 100 22.89 24.34
Injection 150 mg in 1 mL vial PH 1 7.30 10.25
Meloxicam Tablet 7.5 mg BY 30 15.91 17.54
Tablet 15 mg BY 30 23.20 24.83
Metformin Hydrochloride Tablet 500 mg MQ 100 7.73 9.01
AL 100 7.73 9.36
Tablet 850 mg MQ 60 7.73 9.01
AL 60 7.73 9.36
Tablet 1 g AL 90 13.46 15.10
Methyldopa Tablet 250 mg MK 100 6.70 9.29
Methylphenidate Hydrochloride Tablet 10 mg NV 100 7.88 9.47
Methylprednisolone Acetate Injection 40 mg in 1 mL vial PH 5 16.32 16.99
Metoclopramide Hydrochloride Tablet 10 mg VT 25 1.41 4.03
Metoprolol Tartrate Tablet 50 mg NV 100 5.12 7.62
AP 100 5.12 8.07
Tablet 100 mg NV 60 6.50 9.01
AP 60 6.50 9.45
Metronidazole Tablet 400 mg AV 21 4.18 6.00
Tablet 200 mg AV 21 1.78 3.53
Mianserin Hydrochloride Tablet 10 mg OR 50 8.45 10.21
Tablet 20 mg OR 50 17.84 20.47
Minocycline Hydrochloride Tablet equivalent to 50 mg minocycline SI 60 10.52 11.50
Mirtazapine Tablet 30 mg BP 30 24.25 26.23
OR 30 24.25 47.74
Tablet 45 mg BP 30 40.42 42.41
Moclobemide Tablet 150 mg RO 60 14.31 15.15
Tablet 300 mg RO 60 27.54 29.23
Naproxen Tablet 250 mg RO 50 4.23 5.59
Tablet 500 mg RO 50 7.52 9.11
Tablet 750 mg (sustained release) RO 28 6.91 8.38
Tablet 1 g (sustained release) RO 28 9.21 10.77
Naproxen Sodium Tablet 550 mg RO 50 7.75 10.40
Nifedipine Tablet 10 mg BN 60 12.50 14.07
Tablet 20 mg BN 60 15.58 18.49
Tablet 20 mg (controlled release) (unless supplied on an authority prescription) BN 30 15.53 18.53
Tablet 30 mg (controlled release) BN 30 16.75 20.12
Tablet 60 mg (controlled release) BN 30 21.05 24.78
Nitrazepam Tablet 5 mg VT 25 1.70 3.48
Nizatidine Capsule 150 mg AS 60 16.36 21.16
Capsule 300 mg AS 30 16.36 21.16
Norethisterone Tablets 350 micrograms, 28 PH 1 2.37 3.25
Norethisterone with      Ethinyloestradiol Tablets 500 micrograms-35 micrograms, 21 PH 1 2.37 4.12
Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets PH 1 2.37 4.12
Tablets 1 mg-35 micrograms, 21 PH 1 2.37 4.12
Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets PH 1 2.37 4.12
Pack containing 12 tablets 500 micrograms-35 micrograms, 9 tablets 1 mg-35 micrograms and 7 inert tablets PH 1 2.37 4.12
Norfloxacin Tablet 400 mg MK 14 13.11 16.39
Oestradiol Transdermal patches 3.28 mg, 8 NV 1 10.06 11.43
Transdermal patches 4.33 mg, 8 NV 1 10.06 11.43
Transdermal patches 6.57 mg, 8 NV 1 11.98 13.34
Transdermal patches 8.66 mg, 8 NV 1 11.98 13.34
Omeprazole Magnesium Tablet equivalent to 20 mg omeprazole AP 30 26.57 29.07
Ondansetron Wafer 4 mg GK 4 30.51 31.13
GK 10 76.26 76.89
Wafer 8 mg GK 4 47.79 48.42
GK 10 119.47 120.09
Ondansetron Hydrochloride Dihydrate Tablet equivalent to 4 mg ondansetron GK 4 30.51 31.13
GK 10 76.26 76.89
Tablet equivalent to 8 mg ondansetron GK 4 47.79 48.42
GK 10 119.47 120.09
I.V. injection equivalent to 4 mg ondansetron in 2 mL ampoule GK 1 17.20 17.83
I.V. injection equivalent to 8 mg ondansetron in 4 mL ampoule GK 1 27.33 27.94
Oxazepam Tablet 15 mg SI 25 1.13 2.71
Tablet 30 mg SI 25 1.31 2.99
Paracetamol Tablet 665 mg (modified release) GC 96 2.97 5.12
Paraffin - Soft White with Paraffin - Liquid Eye ointment, compound, 3.5 g AQ 1 6.34 7.21
Pack containing 2 tubes eye ointment, compound, 3.5 g AG 1 12.67 14.56
Paroxetine Hydrochloride Tablet equivalent to 20 mg paroxetine GK 30 22.09 23.09
Pemetrexed Disodium Heptahydrate Powder for I.V. infusion equivalent to 500 mg pemetrexed, vial (unless supplied on an authority prescription) LY 1 1430.56 1629.92
Phenoxymethylpenicillin Benzathine Oral suspension equivalent to 125 mg phenoxymethylpenicillin per 5 mL, 100 mL SI 1 3.34 4.16
Oral suspension equivalent to 250 mg phenoxymethylpenicillin per 5 mL, 100 mL SI 1 4.56 5.38
Pilocarpine Hydrochloride Eye drops 10 mg per mL, 15 mL AG 1 5.01 7.31
Eye drops 20 mg per mL, 15 mL AG 1 6.03 8.31
Eye drops 40 mg per mL, 15 mL AG 1 8.37 10.64
Eye drops 60 mg per mL, 15 mL AG 1 12.05 14.26
Pindolol Tablet 5 mg NV 100 5.87 8.34
Tablet 15 mg NV 50 8.45 10.90
Piperazine Oestrone Sulfate Tablet 730 micrograms PH 56 4.95 6.25
Tablet 1.46 mg PH 56 7.05 8.37
Piroxicam Dispersible tablet 10 mg PF 50 7.05 9.47
Dispersible tablet 20 mg PF 25 6.70 9.10
Capsule 10 mg PF 50 7.05 9.47
Capsule 20 mg PF 25 6.70 9.10
Polyvinyl Alcohol Eye drops 14 mg per mL, 15 mL AG 1 3.63 5.14
Eye drops 30 mg per mL, 15 mL AG 1 3.63 8.90
Potassium Chloride Tablet 600 mg (sustained release) NV 100 2.63 3.89
Potassium Chloride with Potassium Bicarbonate Tablet, effervescent, 14 mmol K+ and 8 mmol Cl- AS 60 5.37 7.68
Pravastatin Sodium Tablet 10 mg BQ 30 22.08 22.51
Tablet 20 mg BQ 30 35.08 35.52
Tablet 40 mg BQ 30 54.64 55.09
Tablet 80 mg BQ 30 83.76 84.21
Prazosin Hydrochloride Tablet equivalent to 1 mg prazosin PF 100 7.19 9.87
Tablet equivalent to 2 mg prazosin PF 100 9.86 12.63
Tablet equivalent to 5 mg prazosin PF 100 16.73 19.72
Prednisolone Tablet 1 mg AS 100 2.09 2.63
Prednisolone Sodium Phosphate Oral solution equivalent to 5 mg prednisolone per mL, 30 mL AS 1 7.06 8.68
Prednisone Tablet 1 mg AS 100 2.09 2.63
Prochlorperazine Maleate Tablet 5 mg AV 25 2.28 4.18
Propranolol Hydrochloride Tablet 10 mg AP 100 2.61 5.34
Tablet 40 mg AP 100 2.73 5.46
Quinapril Hydrochloride Tablet equivalent to 5 mg quinapril PF 30 9.53 9.97
Tablet equivalent to 10 mg quinapril PF 30 13.43 14.03
Tablet equivalent to 20 mg quinapril PF 30 16.56 17.45
Quinine Sulfate Tablet 300 mg AS 50 5.02 6.95
Ramipril Tablet 1.25 mg ML 30 6.35 7.26
AV 30 6.35 9.08
Tablet 2.5 mg ML 30 9.28 10.61
AV 30 9.28 12.01
Tablet 5 mg ML 30 11.64 13.30
AV 30 11.64 14.36
Capsule 10 mg ML 30 20.54 23.47
AV 30 20.54 23.47
Pack containing 7 tablets 2.5 mg, 21 tablets 5 mg and 10 capsules 10 mg (unless supplied on an authority prescription) AV 1 18.09 20.67
Ranitidine Hydrochloride Tablet equivalent to 150 mg ranitidine GK 60 13.28 15.25
Tablet, effervescent, equivalent to 150 mg ranitidine (unless supplied on an authority prescription) GK 30 6.65 8.55
Tablet equivalent to 300 mg ranitidine GK 30 13.28 15.25
Syrup equivalent to 150 mg ranitidine per 10 mL, 300 mL (unless supplied on an authority prescription) GK 1 6.65 7.61
Roxithromycin Tablet 150 mg AV 10 6.18 8.38
Tablet 300 mg AV 5 6.18 8.38
Salbutamol Sulfate Pressurised inhalation equivalent to 100 micrograms salbutamol per dose, 200 doses (CFC-free formulation) MM 1 5.11 5.38
GK 1 5.11 5.56
Nebuliser solution equivalent to 2.5 mg salbutamol in 2.5 mL single dose units, 30 GK 1 8.29 9.26
Nebuliser solution equivalent to 5 mg salbutamol in 2.5 mL single dose units, 30 GK 1 8.76 9.73
Sertraline Hydrochloride Tablet equivalent to 50 mg sertraline PF 30 21.14 21.63
Tablet equivalent to 100 mg sertraline PF 30 21.14 21.63
Simvastatin Tablet 5 mg FR 30 19.56 20.18
MK 30 19.56 20.18
Tablet 10 mg FR 30 27.04 27.65
MK 30 27.04 27.65
Tablet 20 mg FR 30 38.86 39.48
MK 30 38.86 39.48
Tablet 40 mg FR 30 55.93 56.56
MK 30 55.93 56.56
Tablet 80 mg FR 30 80.37 80.98
MK 30 80.37 80.98
Sodium Valproate Tablet 200 mg (enteric coated) SW 100 13.91 14.49
Tablet 500 mg (enteric coated) SW 100 27.54 28.26
Sotalol Hydrochloride Tablet 80 mg BQ 60 10.85 12.31
Tablet 160 mg BQ 60 23.28 24.86
Spironolactone Tablet 25 mg PH 100 7.04 8.71
Tablet 100 mg PH 100 27.71 30.01
Sucralfate Tablet equivalent to 1 g anhydrous sucralfate AS 120 15.96 17.90
Sulfasalazine Tablet 500 mg (enteric coated) PH 100 23.48 24.21
Tamoxifen Citrate Tablet equivalent to 10 mg tamoxifen AP 30 18.82 19.78
Tablet equivalent to 20 mg tamoxifen AP 30 32.62 34.35
Temazepam Tablet 10 mg SI 25 1.70 3.31
Terbinafine Hydrochloride Tablet equivalent to 250 mg terbinafine NV 42 116.85 118.61
Thyroxine Sodium Tablet equivalent to 50 micrograms anhydrous thyroxine sodium SI 200 13.52 14.67
Tablet equivalent to 100 micrograms anhydrous thyroxine sodium SI 200 14.47 15.63
Tablet equivalent to 200 micrograms anhydrous thyroxine sodium SI 200 19.21 20.35
Ticlopidine Hydrochloride Tablet 250 mg RO 60 129.93 131.93
Timolol Maleate Eye drops equivalent to 2.5 mg timolol per mL, 5 mL FR 1 6.24 7.19
Eye drops equivalent to 5 mg timolol per mL, 5 mL FR 1 7.19 8.19
Tinidazole Tablet 500 mg PF 4 2.47 4.69
Topiramate Tablet 25 mg (unless supplied on an authority prescription) JC 60 30.31 32.42
Tablet 50 mg (unless supplied on an authority prescription) JC 60 50.53 52.64
Tablet 100 mg (unless supplied on an authority prescription) JC 60 84.19 86.56
Tablet 200 mg (unless supplied on an authority prescription) JC 60 141.43 143.81
Capsule 15 mg (unless supplied on an authority prescription) JC 60 21.83 23.94
Capsule 25 mg (unless supplied on an authority prescription) JC 60 30.31 32.42
Capsule 50 mg (unless supplied on an authority prescription) JC 60 50.53 52.64
Tramadol Hydrochloride Capsule 50 mg CS 20 3.17 4.49
Tablet 100 mg (sustained release) CS 20 8.63 10.39
Tablet 150 mg (sustained release) CS 20 11.63 13.39
Tablet 200 mg (sustained release) CS 20 14.16 15.91
Trandolapril Capsule 500 micrograms AB 28 7.59 8.95
Capsule 1 mg AB 28 12.06 13.43
Capsule 2 mg AB 28 13.06 14.43
Triamcinolone Acetonide Cream 200 micrograms per g, 100 g SI 1 3.76 5.21
Ointment 200 micrograms per g, 100 g SI 1 3.76 5.21
Triamcinolone Acetonide with Neomycin Sulfate, Gramicidin and Nystatin Ear drops 1 mg-2.5 mg (neomycin)-250 micrograms-100,000 units per g, 7.5 mL BQ 1 2.08 3.04
Ear ointment 1 mg-2.5 mg (neomycin)-250 micrograms-100,000 units per g, 5 g BQ 1 1.65 2.61
Trimethoprim Tablet 300 mg SI 7 2.39 3.59
Trimethoprim with Sulfamethoxazole Tablet 160 mg-800 mg SI 10 3.44 4.72
Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL SI 1 3.05 4.74
Verapamil Hydrochloride Tablet 40 mg AB 100 5.90 6.78
Tablet 80 mg AB 100 10.48 11.36
Tablet 180 mg (sustained release) AB 30 8.46 11.09
Tablet 240 mg (sustained release) AB 30 11.28 13.91

Dated this 14th day of February 2007.

STEPHEN DELLAR

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Delegate of the Minister for Health and Ageing

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0